Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 2, 2012, Pages 345-353

  Verri, M ^a   Pastoris, Ornella ^a   Dossena, M ^a   Aquilani, R ^b   Guerriero, F ^a   Cuzzoni, G ^a   Venturini, L ^a   Ricevuti, G ^a   Bongiorno, A I ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Alzheimer's disease; Mitochondria; Neuroinflammation; Reactive oxygen species

Indexed keywords

ALCOHOL DEHYDROGENASE; ALPHA TOCOPHEROL; AMYLOID; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; ASCORBIC ACID; CALCIUM; GINKGO BILOBA EXTRACT; GLUTATHIONE REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AMYLOID BETA PROTEIN; BETA CAROTENE; CARBONYL DERIVATIVE; CHEMOKINE; COMPLEMENT; CYTOCHROME C OXIDASE; CYTOKINE; ESTRADIOL; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1; INTERLEUKIN 6; MALONALDEHYDE; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE; TESTOSTERONE; UBIQUINOL CYTOCHROME C REDUCTASE;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BIOACCUMULATION; BIOLOGICAL MONITORING; CALCIUM HOMEOSTASIS; CELL DEATH; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; FIBROBLAST; GINKGO BILOBA; HUMAN; MEDLINE; MICROGLIA; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NERVE CELL NETWORK; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; AMYLOID PLAQUE; BRAIN MITOCHONDRION; DEGENERATIVE DISEASE; MACROMOLECULE; MEDIATOR RELEASE; MEMBRANE PERMEABILITY; MILD COGNITIVE IMPAIRMENT; MITOCHONDRIAL TOXICITY; MONITORING; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; RESPIRATORY CHAIN; SYSTEMATIC REVIEW;

EID: 84863694005     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500204     Document Type: Review

References (40)

1. Tillement L, Lecanu L, Papadopoulos V. Alzheimer's disease: effects of β-amyloid on mitochondria. Mitochondrion 2011; 11:13-21.
2. Sas K, Robotka H, Toldi J, Vécsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 2007; 257:221-39. (Pubitemid 46856508)
3. Zheng H, Koo EH. The amyloid precursor protein: beyond amyloid. Mol Neurodegener 2006; 1:5.
4. Shibata M, Yamada S, Kumar SR, et al. Clearance of Alzheimer's amyloid β(1-40)-peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 2000; 106:1489-99. (Pubitemid 32038587)
5. Mamelak M. Alzheimer's disease, oxidative stress and gammahydroxybutyrate. Neurobiol Aging 2007; 28:1340-60. (Pubitemid 47081231)
6. Parihar MS, Brewer GJ. Mitoenergetic failure in Alzheimer disease. Am J Physiol Cell Physiol 2007; 292:C8-23.
7. Hsu MJ, Sheu JR, Lin CH, Shen MY, Hsu CY. Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration. Biochim Biophys Acta 2010; 1800:290-6.
8. Misumi Y, Ando Y, Ueda M, Obayashi K, Jono H, Su Y, Yamashita T, Uchino M. Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy. J Pathol 2009; 219:481-90.
9. Davis CH, Berkowitz ML. Structure of the amyloid-beta (1-42) monomer absorbed to model phospholipid bilayers: a molecular dynamics study. J Phys Chem B 2009; 113:14480-6.
10. Lal R, Lin H, Quist AP. Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm. Biochim Biophys Acta 2007; 1768:1966-75.
11. Hansson Petersen CA, Alikhani N, Behbahani H, et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 2008; 105:13145-50.
12. Govoni S, Lanni C, Racchi M. Advances in understanding the pathogenetic mechanisms of Alzheimer's disease. Funct Neurol 2001; 16:17-30. (Pubitemid 34295890)
13. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298:789-91. (Pubitemid 35231524)
14. Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 2008; 14:45-53.
15. Reddy PH. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol 2009; 218:286-92.
16. Pagani L, Eckert A. Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011; 2011:925050.
17. Lustbader JW, Cirilli M, Lin C, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004; 304:448-52. (Pubitemid 38495942)
18. Moreira PI, Santos MS, Moreno A, Rego AC, Oliveira C. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 2002; 69:257-67. (Pubitemid 34734156)
19. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161:41-54. (Pubitemid 36459078)
20. Csordás G, Thomas AP, Hajnoczky G. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J 1999; 18:96-108. (Pubitemid 29005027)
21. Gasparini L, Benussi L, Bianchetti A, Binetti G, Curti D, Govoni S, Moraschi S, Racchi M, Trabucchi M. Energy metabolism inhibition impairs amyloid precursor protein secretion from Alzheimer's fibroblasts. Neurosci Lett 1999; 263:197-200. (Pubitemid 29158962)
22. Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, Murri L, Rapoport SI, Solaini G. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 2002; 23:371-6. (Pubitemid 34312019)
23. Mancuso M, Filosto M, Bosetti F, et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol 2003; 182:421-6. (Pubitemid 36937094)
24. Schmidt C, Lepsverdize E, Chi SL, Das AM, Pizzo SV, Dityatev A, Schachner M. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol Psychiatry 2008; 13:953-69.
25. Rhein V, Baysang G, Rao S, Meier F, Bonert A, Müller-Spahn F, Eckert A. Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 2009; 29:1063-71.
26. Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 2004; 24:565-75. (Pubitemid 38112390)
27. Aybek H, Ercan F, Asian D, Sahiner T. Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey. Clin Biochem 2007; 40:172-6. (Pubitemid 46108698)
28. Cooper AJ, Kristal BS. Multiple roles of glutathione in the central nervous system. Biol Chem 1997; 378:793-802. (Pubitemid 27388939)
29. Liu H, Harrell LE, Shenvi S, Hagen T, Liu RM. Gender differences in glutathione metabolism in Alzheimer's disease. J Neurosci Res 2005; 79:861-7. (Pubitemid 40476510)
30. Rosario ER, Chang L, Stanczyk FZ, Pike CJ. Age-related testosterone depletion and the development of Alzheimer disease. JAMA 2004; 292:1431-2. (Pubitemid 39258334)
31. Singhal RL, Vijayvargiya R. Studies on glutathione metabolism in ventral prostate and chemically induced prostatic carcinoma in rats. Biosci Rep 1983; 3:241-53. (Pubitemid 13069864)
32. Bermejo P, Martín-Aragón S, Benedí J, Susín C, Felici E, Gil P, Ribera JM, Villar AM. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment. Free Radic Res 2008; 42:162-70. (Pubitemid 351298365)
33. Casado A, Encarnación López-Fernández M, Concepción Casado M, de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 2008; 33:450-8. (Pubitemid 351230446)
34. Heneka MT, O'Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 2010; 117:919-47.
35. Salminen A, Ojala J, Suuronen T, Kaarniranta K, Kauppinen A. Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med 2008; 12:2255-62.
36. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009; 87:181-94.
37. McAlpine FE, Lee JK, Harms AS, et al. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis 2009; 34:163-77.
38. Rhein V, Giese M, Baysang G, Meier F, Rao S, Schulz KL, Hamburger M, Eckert A. Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure. PLoS One 2010; 5:e12359.
39. Yao Z, Drieu K, Papadopoulos V. The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands. Brain Res 2001; 889:181-90. (Pubitemid 32146280)
40. Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004; 23:159-69. (Pubitemid 38980441)